Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1963 1
1964 2
1965 2
1966 2
1968 2
1970 1
1977 4
1978 1
1981 4
1982 2
1983 1
1984 2
1985 1
1986 2
1987 2
1990 1
2008 2
2009 3
2010 2
2011 3
2012 3
2013 9
2014 3
2015 2
2016 6
2017 2
2018 5
2019 4
2020 6
2021 11
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Toxic epidermal necrolysis (Lyell's disease).
Lissia M, Mulas P, Bulla A, Rubino C. Lissia M, et al. Among authors: bulla a. Burns. 2010 Mar;36(2):152-63. doi: 10.1016/j.burns.2009.06.213. Epub 2009 Sep 18. Burns. 2010. PMID: 19766401 Review.
Creating the Components for Teaching Concepts.
Johnson K, Bulla AJ. Johnson K, et al. Among authors: bulla aj. Behav Anal Pract. 2021 Jul 29;14(3):785-792. doi: 10.1007/s40617-021-00626-z. eCollection 2021 Sep. Behav Anal Pract. 2021. PMID: 34631382 Free PMC article.
The esthetic outcome of lower limb reconstruction.
Bulla A, Delgove A, De Luca L, Pelissier P, Casoli V. Bulla A, et al. Ann Chir Plast Esthet. 2020 Nov;65(5-6):655-666. doi: 10.1016/j.anplas.2020.07.007. Epub 2020 Aug 13. Ann Chir Plast Esthet. 2020. PMID: 32800462
A New Approach to Upper Eyelid Reconstruction.
Bulla A, Vielà C, Fiorot L, Bolletta A, Pancrazi E, Campus GV. Bulla A, et al. Aesthetic Plast Surg. 2017 Apr;41(2):346-351. doi: 10.1007/s00266-017-0816-0. Epub 2017 Feb 15. Aesthetic Plast Surg. 2017. PMID: 28204937
A Treatment-free Interval Allowed by Ponatinib as Fourth-line Therapy.
Bulla A, Markovic U, Bellofiore C, Stella S, Conticello C, DI Raimondo F, Stagno F. Bulla A, et al. Cancer Diagn Progn. 2021 Mar 3;1(1):19-22. doi: 10.21873/cdp.10003. eCollection 2021 Mar-Apr. Cancer Diagn Progn. 2021. PMID: 35399694 Free PMC article.
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey.
Markovic U, Romano A, Del Fabro V, Bellofiore C, Bulla A, Parisi MS, Leotta S, Gentile M, Cangialosi C, Vincelli I, Mineo G, Rossi M, Poidomani M, Uccello G, Maugeri C, Mannina D, Innao V, Di Raimondo F, Conticello C. Markovic U, et al. Among authors: bulla a. Front Oncol. 2021 Mar 5;11:624405. doi: 10.3389/fonc.2021.624405. eCollection 2021. Front Oncol. 2021. PMID: 33763359 Free PMC article.
85 results